|
Counting
the pills
The basic criteria for an efficient contraceptive drug are
reliability, effectiveness and reversibilty. In the absence
of a wholly satisfactory contraceptive for women, and none
at all for men, the market will always remain hungry for the
perfect pill. Aashruti Kak traces the moves of the contraceptive
market
J&J
sees Pfizer deal breaking even a year earlier
Johnson & Johnson (J&J) said that it expects its $16.6
billion acquisition of Pfizer Consumer Health to break even
or increase earnings modestly by 2009, a year earlier than
previously expected.
Presenting
Neuland in a new avatar
From being a bulk drug and API manufacturer, Neuland is focusing
on contract research and clinical research services to broad
base its revenue stream. Saharsh R Davuluri, Vice President-Corporate
Planning and Development, Neuland Laboratories, speaks to
Aashruti Kak about how they plan to take the company to the
next level
'India
is considered to be a 'next wave' country for HIV/AIDS'
With increasing prevalence and rising incidence of HIV in
India, how well equipped are Indian drug manufacturers to
handle the same. T Vijayakumar, Senior Manager-Export Formulations,
Aurobindo Pharma discusses the antiretrovirals (ARV) market,
in conversation with Arshiya Khan. Excerpts
Taro
calls off merger with Sun Pharma
Israel's Taro Pharmaceuticals recently terminated its merger
agreement with Sun Pharma.
Dr
Reddy's launched 'Atocor-R'
Dr Reddy's Laboratories has launched Atocor-R (atorvastatin
+ ramipril) in India.
Bal
Pharma gets approval from UAE for Ashwamedh
Bal Vedics, the herbal arm of Bal Pharma, has received approval
from the Drugs Control Department, Ministry of Health, United
Arab Emirates (UAE), for its ayurvedic drug, Ashwamedh, a
re-vitaliser for male libido, to promote in the UAE region.
Piramal
Life Sciences becomes a listed company
Piramal Life Sciences Limited (PLSL), an R&D company demerged
from Piramal Healthcare Limited (PHL), was listed on the National
Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
PLSL has a number of molecules in its research pipeline.
NMIMS
launches programs for pharma students
School of Pharmacy and Technology Management of NMIMS University,
Mumbai, launched one year full time Post-Graduate Diploma
Programs in Drug Regulatory Affairs (PGDRA), P G Diploma in
Pharmaceuticals Marketing (PGDPM) and two year full time M
Sc program in Applied Pharm Analysis/Applied Pharm Bioinformatics
and Applied Pharm Microbiology.
Ranbaxy
on an alliance spree
Ranbaxy started its operation in Yemen by tying up with a
local firm, Pharma and by showcasing Ranbaxy's products in
an event to around 350 Doctors.
Glenmark
Generics receives ANDA approvals
Glenmark Generics Limited (GGL), a subsidiary of Glenmark
has received ANDA approvals for mometasone furoate ointment
USP, 0.1 percent, mometasone furoate cream USP, 0.1 percent
and metformin hydrochloride tablets USP 500 mg, 850 mg and
1,000 mg and will soon commence marketing and distribution
of these products in US market.
Additional
certification of ASU opposed in Karnataka
The ayurveda industry of Karnataka is opposing the Union Commerce
Ministry's proposal to put into practice 'certification scheme'
for the exporters of Ayurveda, Siddha and Unani (ASU) under
which all the ASU products will be subject to quality control
and inspection by Export Inspection Council (EIC), an arm
of Commerce Ministry, before exporting these products.
Zydus
Cadila acquires Simayla Pharmaceuticals
India's fourth largest drug manufacturer Zydus Cadila has
acquired 70 per cent stake in Simayla Pharmaceuticals of South
Africa through its wholly owned subsidiary Zydus Healthcare
SA PTY for an undisclosed amount.
Events
Meeting
the challenges
In recent years there has been increase in the number of clinical
research organisations (CROs) in India. A recent seminar on
'Global clinical trial management and logistics' focussed
on the reasons behind this boom and what is needed to keep
it going. Suja Nair reports
Boston
Analytics launches India Watch series
Boston Analytics has recently unveiled a monthly India Watch
series that will provide research reports on trends in various
verticals, including healthcare, in India.
|
